Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Computational model of cardiomyocyte apoptosis identifies mechanisms of tyrosine kinase inhibitor-induced cardiotoxicity

Journal of Molecular and Cellular Cardiology(2021)10.1016/j.yjmcc.2021.02.014Source: DataRank Database

Computational model of cardiomyocyte apoptosis identifies mechanisms of tyrosine kinase inhibitor-induced cardiotoxicity is a research paper published in Journal of Molecular and Cellular Cardiology (2021). On theSindex it has a DataRank of 0.524. It has been cited 32 times.

N/A

0.524DataRank · unranked

Scored on demand from live citation data

Open Access32 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 3.21)OA: greenTopics (54)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.524

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (4)

Bryan Chun,Raquel Moya ORCID,Jeffrey J. Saucerman ORCID,Monika E. Grabowska ORCID

Live enrichment

PubMed:33667419 OpenAlex:https://openalex.org/W3135359150

NHLBI NIH HHS

Grant: R01 HL137100

NHLBI NIH HHS

Grant: R01 HL137755

NHLBI NIH HHS

Grant: U54 HL127624

FWCI

3.21

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2024

2025

2026

greenLicense: https://doi.org/10.15223/policy-004

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8154673

publisherhttps://api.elsevier.com/content/article/PII:S0022282821000511?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0022282821000511?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.yjmcc.2021.02.014

Fields of Study

Chemotherapy-induced cardiotoxicity and mitigationChronic Myeloid Leukemia TreatmentsSynthesis of Tetrazole DerivativesAntineoplastic AgentsApoptosisBiomarkersCardiotoxicityComputational BiologyDisease SusceptibilityGene Regulatory NetworksHumansModels, BiologicalMyocytes, CardiacProtein Kinase InhibitorsReproducibility of ResultsSignal Transduction

MeSH Terms

Antineoplastic AgentsDisease SusceptibilityHumansModels, BiologicalReproducibility of ResultsSignal TransductionBiomarkersApoptosisComputational BiologyMyocytes, CardiacProtein Kinase InhibitorsGene Regulatory NetworksCardiotoxicity

Keywords

SorafenibApoptosisCancer researchTyrosine kinaseTyrosine-kinase inhibitorCardiotoxicityPlatelet-derived growth factor receptorPharmacologySunitinibProtein kinase BPI3K/AKT/mTOR pathwaySignal transductionMedicineChemistryBiologyCell biologyInternal medicineCancerReceptorBiochemistryChemotherapyCardiomyocyteComputational modelSystems biologyTyrosine kinase inhibitor

Sustainable Development Goals

SDG 0: Good health and well-being